This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Miltenyi Biotec, Gmbh, Redona Therapeutics, Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Andrea Aloia: Innovator in Cancer Treatment
Introduction
Andrea Aloia is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of cancer treatment through her innovative work on chimeric antigen receptors. Her research focuses on developing targeted therapies that can improve patient outcomes in oncology.
Latest Patents
Andrea Aloia holds a patent for a chimeric antigen receptor specific for the SSEA4 antigen. This invention provides chimeric antigen receptors (CARs) that comprise an antigen binding domain specific for SSEA4. The patent also includes a population of engineered cells expressing these CARs, along with a pharmaceutical composition that utilizes genetically modified cells for the treatment of cancer. This composition is particularly effective for patients whose cancerous cells express SSEA4.
Career Highlights
Andrea Aloia is currently employed at Miltenyi Biotec GmbH, where she continues to advance her research in the field of immunotherapy. Her work is instrumental in developing innovative solutions for cancer treatment, showcasing her dedication to improving healthcare outcomes.
Collaborations
Some of her notable coworkers include Andreas Bosio and Olaf Hardt, who collaborate with her on various projects aimed at enhancing cancer therapies.
Conclusion
Andrea Aloia's contributions to cancer treatment through her innovative patents and research at Miltenyi Biotec GmbH highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in targeted cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile